Clinical Trials Browser

Phase 2 × Parkinson Disease 4, Autosomal Dominant Lewy Body × avelumab × Clear all

NCT03076554 2026-01-08

A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy

Phase 2 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Thymoma

NCT02968940 2022-06-29

Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma

Phase 2 Completed

6 enrolled 10 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Glioblastoma, Glioma